Natixis Advisors, L.P. Merck & Co., Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,639,214 shares of MRK stock, worth $146 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,639,214
Previous 1,231,846
33.07%
Holding current value
$146 Million
Previous $140 Million
16.57%
% of portfolio
0.3%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,972Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.46 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.94 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $226B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...